Private Equity 3 Days

Last updated: May 17, 2026, 11:30 PM ET

Fundraising & Early‑Stage Play

Venture‑backed firms continued to attract deep pockets as Eclipse secured a $2.5bn win, a deal that underlines the firm’s bet on “physical‑world” AI hardware after its partner Cerebras’ high‑profile IPO. The momentum spilled over to the marketing stack, where Nectar Social closed a $30m Series A led by Menlo’s Anthology Fund, a vehicle tied to Anthropic’s AI ecosystem. Across the Atlantic, Dutch drone maker Destinus entered “€200m funding talks” that could push its autonomous‑flight platform toward commercial rollout, underscoring private capital’s appetite for tangible AI applications.

Mega‑Cap Defense & Tech Raises

The week’s headline‑making round came from defense tech unicorn Anduril, which announced a $5 billion financing package that dwarfed other large rounds and signaled strong investor confidence in battlefield‑grade AI and autonomous systems. Meanwhile, Cerebras, the AI‑chip darling that once “burned $8m a month” to perfect its wafer‑scale processor, highlighted how survivorship bias can reward capital that endures early cash drains before a blockbuster IPO.

Strategic Mergers & Take‑Privates

In the middle market, a cross‑border merger saw Charlesbank‑backed Tecomet combine with Nordic‑backed Orchid Orthopedic Solutions, creating a unified orthopedic platform that will operate under the Tecomet name and expand its European footprint. Parallel to that, Kinderhook completed the take‑private acquisition of Enhabit Home Health & Hospice, adding a sizable home‑care network to its portfolio and positioning the firm for consolidation in the fragmented senior‑service sector.

Private‑Equity Restructuring & Debt Plays

At the senior‑debt frontier, Blackstone and KKR led a direct‑lender consortium that will restructure Affordable Care, writing off roughly 70% of its debt and effectively taking control of the health‑services provider—a move that reflects private equity’s increasing reliance on balance‑sheet‑heavy lenders to execute carve‑outs. In Europe, CPP Investments pledged €400 million alongside Blackstone to acquire a minority stake in French last‑mile logistics platform Proudreed, a bet on e‑commerce‑driven distribution networks that complements Blackstone’s broader logistics push.

Sector‑Focused Platform Investments

Life‑science advisory firms attracted multiple suitors as Blackstone, Audax and Five Arrows signaled interest in pharmaceutical and consulting outfits, while Eir Partners backed Quartz Bio to tap data‑analytics opportunities in drug R&D, illustrating a wave of platform‑building activity aimed at de‑risking complex biotech pipelines. In the testing and inspection arena, Ardian, Blackstone, Bridgepoint and EQT each closed deals targeting revenue‑stable TICC businesses, a segment prized for its predictable cash flows amid broader market volatility.

Operational Wins & Legal Outcomes

Private‑equity’s operational focus was highlighted by HIG Capital’s acquisition of International Aerospace Coatings, a supplier to OEMs and MRO providers that will broaden HIG’s aerospace exposure and supply‑chain integration capabilities. On the litigation front, Mercury Capital secured a judicial ruling dismissing claims that the firm was a “safe haven for white men only,” a decision that may influence future diversity‑related lawsuits within the industry.

Investor Access & Wealth Allocation

Finally, industry analysts argued that private‑equity’s “private‑wealth moment” is driven by two forces: companies staying private longer and retail allocations to private‑equity funds rising, a trend that could reshape capital‑raising dynamics and pressure traditional fund structures to accommodate longer lock‑ups and lower‑minimum commitments.